Related references
Note: Only part of the references are listed.Effectiveness of antipsychotic drugs in schizophrenia: a 10-year retrospective study in a Korean tertiary hospital
Sanghoon Oh et al.
NPJ SCHIZOPHRENIA (2020)
Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia
Jari Tiihonen et al.
JAMA PSYCHIATRY (2019)
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
Maximilian Huhn et al.
LANCET (2019)
Comparative effectiveness of second generation long-acting injectable antipsychotics based on nationwide database research in Hungary
P. Takacs et al.
PLOS ONE (2019)
Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics A Systematic Review and Meta-analysis of Cohort Studies
Takahiro Masuda et al.
JAMA PSYCHIATRY (2019)
Effectiveness of Long-Acting Injectable vs Oral Antipsychotics in Patients With Schizophrenia: A Meta-analysis of Prospective and Retrospective Cohort Studies
Taishiro Kishimoto et al.
SCHIZOPHRENIA BULLETIN (2018)
Comparative Effectiveness of Antipsychotic Drugs for Rehospitalization in Schizophrenia-A Nationwide Study With 20-Year Follow-up
Heidi Taipale et al.
SCHIZOPHRENIA BULLETIN (2018)
20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia
Jari Tiihonen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Factors associated with health service utilisation for common mental disorders: a systematic review
Tessa Roberts et al.
BMC PSYCHIATRY (2018)
Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician
Lawrence Blonde et al.
ADVANCES IN THERAPY (2018)
Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia
Jari Tiihonen et al.
JAMA PSYCHIATRY (2017)
Treatment continuation of four long-acting antipsychotic medications in the Netherlands and Belgium: A retrospective database study
Flore Decuypere et al.
PLOS ONE (2017)
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders
Cherrie Galletly et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2016)
The incidence of schizophrenia and schizophrenia spectrum disorders in Denmark in the period 2000-2012. A register-based study
Johanne Olivia Gronne Kuhl et al.
SCHIZOPHRENIA RESEARCH (2016)
Critical review of antipsychotic polypharmacy in the treatment of schizophrenia
W. Wolfgang Fleischhacker et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Time to discontinuation of antipsychotic drugs in a schizophrenia cohort: influence of current treatment strategies
Rune A. Kroken et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2014)
Comparison of treatment discontinuation and hospitalization among nonadherent patients initiating depot or oral typical antipsychotic medications
Diego Novick et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2012)
Symptom Recurrence Following Intermittent Treatment in First-Episode Schizophrenia Successfully Treated for 2 Years
Robin Emsley et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Medication for Attention Deficit-Hyperactivity Disorder and Criminality
Paul Lichtenstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Medication adherence in schizophrenia
Francisco Javier Acosta et al.
WORLD JOURNAL OF PSYCHIATRY (2012)
Relapse Prevention in First-Episode Schizophrenia-Maintenance vs Intermittent Drug Treatment With Prodrome-Based Early Intervention: Results of a Randomized Controlled Trial Within the German Research Network on Schizophrenia
Wolfgang Gaebel et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Low Dose vs Standard Dose of Antipsychotics for Relapse Prevention in Schizophrenia: Meta-analysis
Hiroyuki Uchida et al.
SCHIZOPHRENIA BULLETIN (2011)
International Consensus Study of Antipsychotic Dosing
David M. Gardner et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Efficacy of atypical v. typical antipsychotics in the treatment of early psychosis: meta-analysis
Nicolas A. Crossley et al.
BRITISH JOURNAL OF PSYCHIATRY (2010)
Adherence and persistence to typical and atypical antipsychotics in the naturalistic treatment of patients with schizophrenia
Haya Ascher-Svanum
Patient Preference and Adherence (2010)
A Randomized Controlled Trial of Long-Acting Injectable Risperidone vs Continuation on Oral Atypical Antipsychotics for First-Episode Schizophrenia Patients: Initial Adherence Outcome
Peter J. Weiden et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys
Philip S. Wang et al.
LANCET (2007)
Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: A randomized, double-blind trial of olanzapine versus haloperidol
JA Lieberman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature
JP Lacro et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Antipsychotic medication adherence: Is there a difference between typical and atypical agents?
CR Dolder et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Medication continuation and compliance: A comparison of patients treated with clozapine and haloperidol
R Rosenheck et al.
JOURNAL OF CLINICAL PSYCHIATRY (2000)
Share Paper
